From January 1, 2023 to March 31, 2023, the company has repurchased 445,000 shares, representing 0.08% for CNY 2.65 million. With this, the company has completed the repurchase of 7,643,500 shares, representing 1.36% for CNY 40.3 million under the buyback announced on July 15, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.58 CNY | -3.78% | -6.15% | -25.29% |
1st Jan change | Capi. | |
---|---|---|
-25.29% | 353M | |
+42.60% | 748B | |
+33.78% | 598B | |
-5.74% | 356B | |
+17.79% | 325B | |
+3.37% | 283B | |
+17.17% | 245B | |
+9.39% | 211B | |
-3.76% | 209B | |
+1.81% | 166B |
- Stock Market
- Equities
- 600222 Stock
- News Henan Taloph Pharmaceutical Stock Co.,Ltd
- Tranche Update on Henan Taloph Pharmaceutical Stock Co.,Ltd's Equity Buyback Plan announced on July 15, 2022.